September 26, 2011 – 10:47 am
The second Rocky Mountain Life Science Investor and Partnering Conference brought together a diverse group of 31 companies and investors at the Brown Palace hotel on Friday. The program included discussion of the Barbara Davis Center for Childhood Diabetes and The Center for Regenerative Medicine and Stem Cell Biology at the University of Colorado [...]
Sophono announced that it has received FDA clearance for its implantable Otomag Alpha 1(M) Bone Conduction Hearing System. The Alpha 1(M) can treat several hearing disorders including conductive and mixed hearing loss, as well as single sided deafness. The offers distinct advantages from current implanted bone conduction hearing devices that require an abutment [...]
The Boettcher Foundation announced its second class of investigators in the Webb-Waring Biomedical Research Program. This program provides grants of between $200,000 and $300,000 to assist early-career investigators (ECIs) engaged in biomedical science research in Colorado. These grants provide ECIs, defined as those who are four years or less from their first academic appointment [...]
The Second Annual GoldLab Symposium brought together a diverse group of presenters for a two day event. According to Larry Gold, the leader of the event and founder and CEO of Somalogic, this year’s event had a dual focus on the various “omics” – genomics, proteomics, transcriptionomics, etc – and on medical infrastructure and [...]
AmideBio announced that it has closed a $575,000 preferred equity financing round. The source of the funds was not disclosed. AmideBio uses proprietary “Cap-Clip” technology, exclusively licensed from the University of Colorado, to produce and commercialize technically challenging peptides. This technology has the potential to both lower costs and improve purity in peptide [...]
The FDA announced the approval of the KeyPath MRSA/MSSA Blood Culture Test, manufactured by MicroPhage, Inc. The test can identify whether the bacteria in a patient’s blood culture sample is methicillin resistant (MRSA) or methicillin susceptible (MSSA) Staphylococcus aureus within five hours after the first bacterial growth in the sample – compared to the [...]
Cerapedics, Inc announced results of a prospective, randomized, controlled trial of its i-FACTOR™ biologic bone graft for patients undergoing posterior lumbar interbody fusion (PLIF) spine procedures. The trial, which was conducted in Europe, was designed to evaluate the safety and efficacy of Cerapedics’ novel i-FACTOR biologic bone graft compared to autologous bone graft. At [...]
Array BioPharma announced the achievement of a $10 million clinical research milestone in its development collaboration with Novartis. This milestone was reached after Novartis reported the first patient visit in a Phase 2 clinical trial of MEK162. The open-label study will evaluate the safety and efficacy of MEK162 in patients with malignant cutaneous [...]
BiOptix Diagnosics, Inc announced the closing of a $9M Series B round. The round was led by The Russian Corporation for Nanotechnologies (“RUSNANO”) and joined by Boulder Ventures, which led the company’s series A financing, and several private investors. The funds will be used to expand marketing and establish a subsidiary in Russia [...]
December 9, 2010 – 2:06 pm
December’s BioBreakfast featured two of CBSA’s 2010 award winning companies. The companies – Amgen, which won Company of the Year honors, and Sharklet Technologies, which was named the Rising Star – showcase the spectrum of bioscience activity going on within the state. Amgen has been in business for 30 years and employs about 17,000 worldwide. [...]
